BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6248213)

  • 1. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F; Pavelic Z; Mihich E
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ; Ryoyama K; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting suppressor cell activity in tumor-allosensitized mice.
    Argyris BF
    J Natl Cancer Inst; 1980 Apr; 64(4):959-66. PubMed ID: 6445017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 8. Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.
    Faanes RB; Dillon P; Choi YS
    Clin Exp Immunol; 1977 Mar; 27(3):502-6. PubMed ID: 405166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
    Purves EC
    Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
    Przepiorka D; Mokyr MB; Dray S
    Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple tumoricidal effector mechanisms induced by adriamycin.
    Salazar D; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2561-6. PubMed ID: 6327018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adriamycin on the activity of mouse natural killer cells.
    Santoni A; Riccardi C; Sorci V; Herberman RB
    J Immunol; 1980 May; 124(5):2329-35. PubMed ID: 6444969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tumor cell culture supernatants on macrophages.
    Moldoveanu R; Iurascu C; Popp I
    Neoplasma; 1978; 25(3):285-90. PubMed ID: 683373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures.
    Merluzzi VJ; Walker MM; Faanes RB
    Cancer Res; 1981 Mar; 41(3):850-3. PubMed ID: 6450638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The secondary cytotoxic response to allogeneic cells: the specificity of secondary cytotoxic effectors differs from that of primary effectors.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Apr; 51(2):89-95. PubMed ID: 6974264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supernatants from ethanol-containing macrophage cultures have cytotoxic activity.
    Wickramasinghe SN
    Alcohol Alcohol; 1986; 21(3):263-8. PubMed ID: 3464283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.